0,915  0,004  Eye irritation, high
0,877  0,002  Succinate dehydrogenase inhibitor
0,862  0,004  Platelet antagonist
0,857  0,004  GST A substrate
0,827  0,004  Skin irritative effect
0,823  0,004  Lipoprotein disorders treatment
0,829  0,012  Antiinflammatory
0,806  0,008  TNF expression inhibitor
0,795  0,007  Antidiabetic
0,795  0,007  Cyclophilin D inhibitor
0,759  0,005  Atherosclerosis treatment
0,752  0,005  Antithrombotic
0,733  0,006  Antiallergic
0,710  0,007  Cholesterol antagonist
0,708  0,005  Platelet aggregation inhibitor
0,705  0,005  Hypolipemic
0,698  0,005  Antidiabetic (type 2)
0,689  0,017  Teratogen
0,671  0,008  Vasodilator, peripheral
0,662  0,005  Antipruritic, allergic
0,668  0,012  Antihypercholesterolemic
0,668  0,017  Embryotoxic
0,641  0,003  Vanilloid agonist
0,640  0,004  Platelet adhesion inhibitor
0,637  0,003  Acaricide
0,634  0,005  Antihypertriglyceridemic
0,636  0,009  NOS3 expression inhibitor
0,618  0,005  Antiglaucomic
0,629  0,018  CYP2C9 substrate
0,619  0,008  Apoptosis antagonist
0,615  0,005  Antidiabetic symptomatic
0,604  0,010  Cardioprotectant
0,604  0,017  Toll-Like receptor agonist
0,588  0,009  Hypoglycemic
0,605  0,035  Caspase 9 stimulant
0,588  0,019  Antiasthmatic
0,569  0,003  Phospholipase A2 inhibitor
0,582  0,019  Toll-Like receptor 7 agonist
0,572  0,016  Mutagenic
0,567  0,013  Antipsoriatic
0,559  0,005  Antiulcerative
0,562  0,010  FMO1 substrate
0,555  0,004  Mediator release inhibitor
0,548  0,009  Vasodilator
0,581  0,053  Apoptosis agonist
0,543  0,016  Hepatic disorders treatment
0,534  0,009  Vascular (periferal) disease treatment
0,523  0,005  VCAM1 expression inhibitor
0,522  0,004  GST P1-1 substrate
0,533  0,021  Carcinogenic
0,519  0,009  ICAM1 expression inhibitor
0,503  0,005  Alpha-N-acetylglucosaminidase inhibitor
0,537  0,039  Transcription factor NF kappa B inhibitor
0,495  0,004  Antihyperlipoproteinemic
0,501  0,010  Antihypoxic
0,502  0,023  Ulceration
0,505  0,028  Immunostimulant
0,494  0,023  Sensitization
0,509  0,039  CYP3A4 substrate
0,477  0,015  UGT2B4 substrate
0,465  0,004  Antieczematic
0,477  0,022  Lipoxygenase inhibitor
0,460  0,009  Diabetic retinopathy treatment
0,470  0,022  Metabolic disease treatment
0,446  0,005  Antipruritic, non-allergic
0,438  0,003  Alcohol dehydrogenase substrate
0,435  0,010  Non-steroidal antiinflammatory agent
0,450  0,028  Analeptic
0,451  0,031  Spasmolytic
0,438  0,022  Antipyretic
0,460  0,045  Histamine release inhibitor
0,426  0,013  Septic shock treatment
0,443  0,030  Radioprotector
0,412  0,010  Phospholipase C inhibitor
0,430  0,030  Antioxidant
0,414  0,014  Abortion inducer
0,405  0,005  Acute respiratory distress syndrome (ARDS) treatment
0,435  0,042  Aldehyde oxidase inhibitor
0,401  0,008  Protein kinase stimulant
0,423  0,030  UGT1A9 substrate
0,411  0,020  Myocardial infarction treatment
0,393  0,003  Vanilloid 1 agonist
0,402  0,016  Antimutagenic
0,423  0,038  Immunomodulator
0,410  0,025  Radiosensitizer
0,406  0,021  Angiogenesis stimulant
0,418  0,033  CTGF expression inhibitor
0,422  0,038  Caspase 3 stimulant
0,391  0,012  Hair growth stimulant
0,398  0,021  UDP-glucuronosyltransferase substrate
0,424  0,052  GABA C receptor rho-3 antagonist
0,409  0,038  Antihypertensive
0,368  0,001  Prostacyclin agonist
0,377  0,011  Tyrosine 3 hydroxylase inhibitor
0,421  0,056  Immunosuppressant
0,414  0,052  Stroke treatment
0,386  0,027  UGT1A6 substrate
0,438  0,086  Antineoplastic (solid tumors)
0,372  0,019  Antiparkinsonian, rigidity relieving
0,355  0,009  Insulin sensitizer
0,368  0,023  Wound healing agent
0,358  0,016  UGT2B7 substrate
0,372  0,032  Tumour necrosis factor alpha release inhibitor
0,421  0,083  Antiarthritic
0,372  0,034  Proliferative diseases treatment
0,348  0,012  Protein-tyrosine phosphatase inhibitor
0,340  0,006  Neurotrophic factor
0,355  0,022  GST M1-1 substrate
0,385  0,053  Bone diseases treatment
0,360  0,031  Antiparasitic
0,332  0,008  GABA C receptor agonist
0,364  0,040  Interleukin 2 agonist
0,351  0,028  Peroxidase inhibitor
0,326  0,004  Transcription factor NF kappa B stimulant
0,326  0,005  Prostaglandin antagonist
0,323  0,002  Prostaglandin D2 agonist
0,327  0,005  Adenylate kinase inhibitor
0,353  0,035  FMO3 substrate
0,330  0,012  Antihelmintic (Nematodes)
0,353  0,038  Sodium/bile acid cotransporter inhibitor
0,343  0,033  Nitric oxide antagonist
0,362  0,052  Respiratory analeptic
0,340  0,032  DNA synthesis inhibitor
0,334  0,026  Anesthetic general
0,316  0,015  Antiparkinsonian, tremor relieving
0,354  0,053  Vasodilator, coronary
0,305  0,005  Peroxisome proliferator-activated receptor gamma agonist
0,312  0,012  Glutathione S-transferase substrate
0,308  0,009  Cell adhesion inhibitor
0,339  0,041  Chronic obstructive pulmonary disease treatment
0,314  0,017  Lipid peroxidase inhibitor
0,384  0,088  5 Hydroxytryptamine release inhibitor
0,340  0,045  Cytotoxic
0,306  0,010  Protein-tyrosine phosphatase 1B inhibitor
0,298  0,004  Leukotriene antagonist
0,298  0,004  Aldehyde dehydrogenase substrate
0,295  0,002  Prostaglandin agonist
0,332  0,048  NOS2 expression inhibitor
0,326  0,044  Cardiovascular analeptic
0,286  0,006  UGT2B10 substrate
0,300  0,023  Antiseptic
0,331  0,056  Antiosteoporotic
0,284  0,009  Ferrochelatase inhibitor
0,293  0,018  Monophenol monooxygenase inhibitor
0,313  0,042  Interleukin agonist
0,271  0,003  Arachidonic acid antagonist
0,271  0,006  Triose-phosphate isomerase inhibitor
0,268  0,003  Peroxisome proliferator-activated receptor alpha agonist
0,277  0,013  Carcinogenic, group 1
0,285  0,023  Urolithiasis treatment
0,275  0,013  5-Lipoxygenase inhibitor
0,284  0,023  Carcinogenic, group 3
0,294  0,033  UGT1A1 substrate
0,269  0,008  Antispirochetal
0,291  0,033  RNA-directed DNA polymerase inhibitor
0,307  0,051  Flavin-containing monooxygenase substrate
0,288  0,033  UGT1A4 substrate
0,347  0,093  CYP2C19 inhibitor
0,262  0,011  ATPase inhibitor
0,258  0,007  Phosphofructokinase-1 inhibitor
0,267  0,017  Insulin secretagoues
0,252  0,005  Alcohol oxidase inhibitor
0,263  0,017  UGT2B9 substrate
0,253  0,009  Toll-Like receptor 2 antagonist
0,258  0,014  Cell wall synthesis inhibitor
0,287  0,043  Gastrin inhibitor
0,263  0,021  Antipruritic
0,345  0,105  Antibacterial
0,261  0,022  Allergic rhinitis treatment
0,292  0,054  Cardiodepressant
0,240  0,003  Thromboxane antagonist
0,341  0,105  15-Lipoxygenase inhibitor
0,243  0,011  UGT2B1 substrate
0,270  0,038  Hepatoprotectant
0,248  0,018  Aldehyde dehydrogenase inhibitor
0,248  0,019  Renal failure treatment
0,327  0,099  Antiobesity
0,228  0,006  Keratolytic
0,250  0,030  UGT1A3 substrate
0,289  0,071  CYP2C19 substrate
0,242  0,025  Antidote
0,298  0,083  AR expression inhibitor
0,233  0,018  Cystathionine beta-synthase inhibitor
0,280  0,065  Chemoprotective
0,260  0,045  Sedative
0,263  0,049  Chemopreventive
0,228  0,015  Expectorant
0,226  0,014  Raynaud's phenomenon treatment
0,224  0,012  Cyclooxygenase 3 inhibitor
0,227  0,016  Antirickettsial
0,225  0,015  Microtubule formation inhibitor
0,271  0,062  Superoxide dismutase inhibitor
0,293  0,085  Antineoplastic (endocrine cancer)
0,218  0,010  Mucolytic
0,209  0,003  Thromboxane A2 antagonist
0,237  0,031  Anesthetic
0,220  0,017  Excitatory amino acid transporter EAAC1 inhibitor
0,207  0,005  GST T1-1 substrate
0,222  0,021  Rhinitis treatment
0,203  0,005  Acyl-CoA dehydrogenase inhibitor
0,242  0,044  P-glycoprotein inhibitor
0,219  0,021  Alkylator
0,224  0,031  Skin whitener
0,220  0,029  Pancreatic disorders treatment
0,214  0,023  Catenin beta inhibitor
0,235  0,045  CYP2B6 inhibitor
0,196  0,007  Prostaglandin EP2 antagonist
0,229  0,041  Lipocortins synthesis antagonist
0,260  0,072  5 Hydroxytryptamine uptake stimulant
0,191  0,005  CDC25B inhibitor
0,190  0,004  Leukotriene B4 antagonist
0,265  0,079  Renal disease treatment
0,201  0,015  Catalase inhibitor
0,220  0,035  Muscular dystrophy treatment
0,198  0,014  Calcium antagonist
0,212  0,030  Uterine stimulant
0,202  0,022  Interleukin 4 antagonist
0,185  0,005  Ca2+-transporting ATPase inhibitor
0,239  0,061  Anticonvulsant
0,186  0,008  Toll-Like receptor 2 agonist
0,215  0,038  Antiacne
0,181  0,005  Restless leg syndrome treatment
0,187  0,012  Actinic keratosis treatment
0,229  0,056  DNA methyltransferase I inhibitor
0,179  0,006  Leukotriene synthesis inhibitor
0,210  0,041  Diuretic
0,200  0,031  Antianemic
0,187  0,019  Coagulant
0,171  0,004  Endocannabinoid uptake inhibitor
0,183  0,017  Photosensitizer
0,259  0,093  Antiepileptic
0,188  0,024  Antiviral (Poxvirus)
0,172  0,009  Anabolic
0,169  0,009  UGT2B11 substrate
0,208  0,048  Thrombolytic
0,170  0,010  Glutamate decarboxylase inhibitor
0,171  0,012  Cell adhesion molecule inhibitor
0,163  0,004  Aconitate hydratase inhibitor
0,199  0,040  CNS active muscle relaxant
0,169  0,010  CDC25A inhibitor
0,162  0,003  Lysophosphatidic acid 2 receptor antagonist
0,173  0,014  Prolactin inhibitor
0,162  0,004  Prostaglandin D2 antagonist
0,216  0,060  Antihelmintic
0,165  0,010  Carbamoyl phosphate synthetase inhibitor
0,180  0,025  Adenylate cyclase stimulant
0,221  0,066  DNA methylase inhibitor
0,175  0,020  Antineoplastic, alkylator
0,170  0,017  Antiviral (Papilloma)
0,172  0,020  GABA C receptor antagonist
0,155  0,003  Prostaglandin E2 agonist
0,244  0,092  5 Hydroxytryptamine release stimulant
0,230  0,078  Free radical scavenger
0,193  0,044  Melanin inhibitor
0,189  0,040  Genotoxic
0,151  0,003  Lysophosphatidic acid 3 receptor antagonist
0,175  0,028  Aminopeptidase B inhibitor
0,189  0,045  Interferon gamma antagonist
0,188  0,044  Skeletal muscle relaxant
0,159  0,016  Electrolyte absorption antagonist
0,153  0,010  Ornithine decarboxylase inhibitor
0,164  0,022  TRPA1 agonist
0,150  0,008  Antidote, heavy metal
0,156  0,015  Glutamate dehydrogenase inhibitor
0,167  0,026  Choleretic
0,177  0,036  DNA polymerase I inhibitor
0,143  0,004  Prostacyclin antagonist
0,242  0,105  Insulysin inhibitor
0,175  0,039  Anesthetic local
0,244  0,108  Antiischemic
0,137  0,004  Thromboxane synthase inhibitor
0,135  0,004  Peroxisome proliferator-activated receptor delta agonist
0,179  0,049  Corneal wound healing stimulator
0,177  0,047  Aldose reductase substrate
0,132  0,004  Vanilloid 2 antagonist
0,132  0,004  Anesthetic inhalation
0,151  0,023  Creatine kinase inhibitor
0,153  0,025  Gastric antisecretory
0,230  0,105  Antineoplastic (pancreatic cancer)
0,164  0,039  Retinoprotector
0,147  0,023  Toll-Like receptor 4 antagonist
0,210  0,087  Peptidyltransferase inhibitor
0,146  0,023  GABA C receptor rho-1 antagonist
0,134  0,012  ATPase (Vacuolar H+) inhibitor
0,144  0,022  Porphobilinogen synthase inhibitor
0,149  0,029  Caspase 3 inhibitor
0,123  0,003  Leukotriene C antagonist
0,168  0,049  SULT1A3 substrate
0,170  0,051  GABA C receptor rho-2 antagonist
0,166  0,048  Bone formation stimulant
0,121  0,003  Prostaglandin EP4 agonist
0,145  0,027  Sphingomyelinase inhibitor
0,173  0,055  Cyclooxygenase inhibitor
0,131  0,013  Thioredoxin reductase inhibitor
0,131  0,014  Argininosuccinate synthase inhibitor
0,130  0,013  Cannabinoid CB1 receptor agonist
0,120  0,004  Glucose-6-phosphate isomerase inhibitor
0,193  0,081  Pneumotoxic
0,118  0,006  Glutamate (mGluR6) antagonist
0,141  0,029  Antifungal (Pneumocystis)
0,145  0,034  Antiviral (CMV)
0,116  0,005  Leukotriene D4 antagonist
0,140  0,030  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,117  0,007  Antiviral (Parainfluenza)
0,158  0,048  Sphingosine 1-phosphate receptor 5 antagonist
0,166  0,057  Amylase inhibitor
0,149  0,039  Gastritis treatment
0,114  0,004  Retinoid X alpha receptor agonist
0,201  0,092  Antiviral (HIV)
0,126  0,019  Glutathione S-transferase inhibitor
0,131  0,024  Thioredoxin inhibitor
0,130  0,024  NADH dehydrogenase inhibitor
0,121  0,014  Antiviral (Dengue virus)
0,111  0,005  Squalene synthetase inhibitor
0,119  0,014  Antimetabolite
0,128  0,023  Antidote, mercury
0,120  0,015  Hyperparathyroidism treatment
0,151  0,046  Antihemorrhagic
0,109  0,005  Nitric oxide donor
0,136  0,034  UDP-glucose 4-epimerase inhibitor
0,116  0,014  Biliverdin reductase inhibitor
0,144  0,042  Gout treatment
0,141  0,039  Shock treatment
0,144  0,045  Growth stimulant
0,118  0,019  Phenylalanine 4-hydroxylase inhibitor
0,143  0,045  Antineoplastic antimetabolite
0,112  0,014  Ornithine carbamoyltransferase inhibitor
0,145  0,047  Cholesterol synthesis inhibitor
0,202  0,105  Antineoplastic (liver cancer)
0,160  0,063  Pulmonary hypertension treatment
0,220  0,123  Antineoplastic (multiple myeloma)
0,099  0,003  Prostaglandin EP2 agonist
0,165  0,070  Neurotensin receptor agonist
0,133  0,037  Myasthenia Gravis treatment
0,222  0,126  CYP1A2 substrate
0,134  0,039  AMP-activated protein kinase stimulant
0,099  0,005  Retinoid X receptor agonist
0,096  0,003  Leukotriene C4 antagonist
0,157  0,064  UGT2B15 substrate
0,126  0,032  Arylamine N-Acetyltransferase substrate
0,133  0,041  Xanthine oxidase inhibitor
0,217  0,127  CYP2D6 substrate
0,162  0,072  Cystic fibrosis treatment
0,107  0,017  Glycine receptor agonist
0,202  0,112  Antiviral (West Nile virus)
0,112  0,024  Selectin antagonist
0,198  0,110  Antihypotensive
0,238  0,151  Inflammatory Bowel disease treatment
0,110  0,023  Aminopeptidase I inhibitor
0,141  0,054  Sphingosine 1-phosphate receptor 2 antagonist
0,098  0,012  Prostaglandin F2 alpha antagonist
0,100  0,015  Peroxisome proliferator-activated receptor gamma antagonist
0,089  0,004  Membrane dipeptidase inhibitor
0,164  0,080  Macular degeneration treatment
0,098  0,014  Acetyl-CoA transferase inhibitor
0,164  0,080  Muscle relaxant
0,131  0,047  SULT1A1 substrate
0,088  0,004  GABA uptake inhibitor
0,107  0,024  Antiviral (Hepatitis A)
0,099  0,016  Antitreponemal
0,139  0,057  Antibacterial (Helicobacter pylori)
0,115  0,034  Paget's disease treatment
0,140  0,061  Cyclooxygenase 2 inhibitor
0,085  0,006  Fumarate hydratase inhibitor
0,104  0,025  Interferon agonist
0,081  0,002  Prostaglandin F2 alpha agonist
0,178  0,100  Neurotrophic factor enhancer
0,079  0,002  Lysophosphatidic acid receptor 1 agonist
0,089  0,012  Antiviral (Herpesvirus 3, Human)
0,101  0,025  Sphingosine 1-phosphate receptor 4 agonist
0,152  0,077  Restenosis treatment
0,090  0,015  Exportin-1 inhibitor
0,141  0,066  Antifungal enhancer
0,079  0,005  Peroxisome proliferator-activated receptor alpha antagonist
0,104  0,030  Granulocyte macrophage colony stimulating factor agonist
0,212  0,139  Antifungal
0,126  0,055  Antiviral (Influenza B)
0,118  0,048  Antiprotozoal (Toxoplasma)
0,081  0,011  Alpha-mannosidase inhibitor
0,097  0,027  Narcotic antagonist
0,090  0,020  Aldose reductase inhibitor
0,097  0,028  Estrogen-related receptor beta agonist
0,117  0,048  DOPA decarboxylase inhibitor
0,101  0,034  Antibiotic
0,071  0,004  Kainate receptor agonist
0,187  0,121  Acute neurologic disorders treatment
0,128  0,062  Antiviral (Hepatitis B)
0,085  0,020  Interferon inducer
0,113  0,050  Sulfotransferase substrate
0,090  0,027  Antidote, organophosphates
0,065  0,002  Lysophosphatidic acid receptor 3 agonist
0,089  0,027  Vanilloid 4 agonist
0,146  0,085  Neuropathy treatment
0,075  0,014  Oleamide hydrolase inhibitor
0,096  0,036  Na+ K+ transporting ATPase inhibitor
0,097  0,037  Macrophage migration inhibitory factor inhibitor
0,163  0,103  Sepsis treatment
0,145  0,086  CF transmembrane conductance regulator agonist
0,122  0,063  Retinopathy treatment
0,081  0,023  SULT2A1 substrate
0,125  0,069  Cathepsin H inhibitor
0,081  0,024  Ribonucleoside-diphosphate reductase inhibitor
0,061  0,006  Retinoid X receptor antagonist
0,077  0,022  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,081  0,026  Ribonucleotide reductase inhibitor
0,058  0,004  Lysophosphatidic acid 1 receptor antagonist
0,094  0,040  mTOR complex 2 inhibitor
0,060  0,006  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,142  0,089  Movement disorders treatment
0,158  0,104  Antiviral (Hepatitis)
0,068  0,015  Phosphate transporter inhibitor
0,065  0,014  Mannosidase inhibitor
0,085  0,034  Amidase inhibitor
0,057  0,007  Sodium-dependent vitamin C transporter 2 inhibitor
0,108  0,060  HDL-cholesterol increasing
0,065  0,017  Adenosine deaminase inhibitor
0,053  0,005  Retinoid X alpha receptor antagonist
0,066  0,019  Pregnane X receptor antagonist
0,051  0,004  Calcium-independent phospholipase A2 inhibitor
0,139  0,092  Hexokinase inhibitor
0,068  0,021  Glycine transporter 2 inhibitor
0,052  0,006  Leukotriene B4 receptor 1 antagonist
0,099  0,054  Alcohol dehydrogenase inhibitor
0,056  0,011  Acetyl-CoA transferase 1 inhibitor
0,048  0,004  Prostaglandin H2 antagonist
0,100  0,056  Lanosterol 14 alpha demethylase inhibitor
0,099  0,055  HIV-1 integrase (Overall Integration) inhibitor
0,082  0,038  GABA B receptor agonist
0,072  0,029  Antimycoplasmal
0,082  0,041  Histidine decarboxylase inhibitor
0,042  0,002  Thromboxane agonist
0,142  0,103  Hearing loss treatment
0,043  0,004  G-protein-coupled receptor 120 agonist
0,041  0,002  Thromboxane A2 agonist
0,047  0,009  Prostaglandin EP4 antagonist
0,086  0,048  Antiviral (RSV)
0,049  0,012  Glutamate (mGluR8) agonist
0,041  0,005  Leukotriene B4 receptor 2 antagonist
0,140  0,105  Antiviral (Hepatitis C)
0,064  0,029  Lipocortins synthesis agonist
0,081  0,046  GABA aminotransferase inhibitor
0,061  0,027  Sphingosine 1-phosphate receptor 1 antagonist
0,055  0,021  Microtubule stabilization
0,062  0,029  Sphingosine kinase 2 inhibitor
0,070  0,036  NMDA receptor agonist
0,055  0,022  Purinergic P2Y antagonist
0,049  0,017  Kainate receptor 2 antagonist
0,064  0,032  Sphingosine kinase inhibitor
0,061  0,030  Glucosylceramidase inhibitor
0,035  0,004  Calcium-dependent phospholipase A2 inhibitor
0,035  0,004  Retinoid X beta receptor antagonist
0,042  0,011  Hypoxanthine phosphoribosyltransferase inhibitor
0,113  0,082  Contraceptive female
0,115  0,085  Cyclooxygenase 1 inhibitor
0,043  0,013  Peroxisome proliferator-activated receptor delta antagonist
0,074  0,045  Phospholipase D inhibitor
0,041  0,012  Uridine phosphorylase inhibitor
0,033  0,004  Carbonic anhydrase X inhibitor
0,033  0,004  Carbonic anhydrase VIII inhibitor
0,114  0,085  Sphingosine 1-phosphate receptor 4 antagonist
0,068  0,041  Beta adrenoreceptor antagonist
0,090  0,062  Glutamate release inhibitor
0,048  0,022  Kainate receptor antagonist
0,082  0,056  Antineoplastic antibiotic
0,044  0,019  Cholesterol absorption inhibitor
0,105  0,080  Proteasome inhibitor
0,055  0,030  GP IIb/IIIa receptor antagonist
0,040  0,015  HMG CoA reductase inhibitor
0,144  0,120  LDLR expression enhancer
0,070  0,046  Anticholelithogenic
0,037  0,013  Glutamate (mGluR3) agonist
0,058  0,035  Acetyl-CoA transferase 2 inhibitor
0,032  0,009  Retinoid X gamma receptor antagonist
0,093  0,071  Carbonic anhydrase III inhibitor
0,026  0,004  Vitamin D receptor agonist
0,045  0,023  Liver X receptor alpha agonist
0,214  0,192  Calcium channel activator
0,052  0,030  Squalene epoxidase inhibitor
0,037  0,016  GABA transporter 3 inhibitor
0,039  0,018  Ceramide glucosyltransferase inhibitor
0,027  0,007  GABA transporter inhibitor
0,079  0,059  Glycine receptor antagonist
0,187  0,167  12-Lipoxygenase inhibitor
0,027  0,007  Free fatty acid receptor 1 agonist
0,064  0,045  Neuraminidase (influenza) inhibitor
0,146  0,128  Phobic disorders treatment
0,041  0,023  Cholecystokinin B agonist
0,066  0,049  Potassium channel large-conductance Ca-activated activator
0,025  0,008  Retinoic acid beta receptor agonist
0,067  0,050  Gaucher disease treatment
0,061  0,045  NMDA receptor glycine site agonist
0,160  0,144  Cytostatic
0,049  0,033  Cytokine production stimulant
0,069  0,054  Calcium channel L-type blocker
0,056  0,041  Fatty acid synthase inhibitor
0,033  0,018  Prostaglandin EP3 antagonist
0,029  0,014  Thyroid hormone agonist
0,042  0,029  Angiotensin AT1 receptor antagonist
0,027  0,014  Purinergic P2Y12 antagonist
0,061  0,047  Beta 2 adrenoreceptor agonist
0,025  0,011  Isoleucine-tRNA ligase inhibitor
0,088  0,075  Interleukin 1 beta converting enzyme inhibitor
0,031  0,018  Liver X receptor beta antagonist
0,154  0,141  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,037  0,025  Glutamate (mGluR3) antagonist
0,056  0,044  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,018  0,006  GABA transporter 1 inhibitor
0,062  0,050  Beta 3 adrenoreceptor antagonist
0,043  0,032  Sphingosine 1-phosphate receptor agonist
0,143  0,132  Toxic, respiratory center
0,030  0,019  Liver X receptor alpha antagonist
0,026  0,016  Vanilloid 2 agonist
0,026  0,015  Glutamate (mGluR1) agonist
0,037  0,026  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,020  0,009  Methylmalonyl-CoA mutase inhibitor
0,073  0,063  Sphingosine 1-phosphate receptor antagonist
0,057  0,047  Neuraminidase inhibitor
0,137  0,127  Aldehyde oxidase substrate
0,037  0,028  NMDA receptor subunit 3A antagonist
0,035  0,026  Arginase inhibitor
0,018  0,009  Thyroid hormone alpha agonist
0,030  0,022  Elastase 3B inhibitor
0,030  0,022  Elastase 2B inhibitor
0,030  0,022  Elastase 3A inhibitor
0,051  0,043  Sphingosine 1-phosphate receptor 5 agonist
0,040  0,032  Sphingosine kinase 1 inhibitor
0,046  0,039  HCV NS3/NS4A protease inhibitor
0,022  0,016  Retinoic acid gamma receptor agonist
0,013  0,007  Glutamate (mGluR6) agonist
0,017  0,011  O6-alkylguanine-DNA alkyltransferase inhibitor
0,034  0,029  Glutamate (mGluR8) antagonist
0,022  0,017  Retinoic acid receptor agonist
0,031  0,027  Free fatty acid receptor 1 antagonist
0,135  0,131  Psychostimulant
0,017  0,013  Telomerase stimulant
0,039  0,035  Leukocyte elastase inhibitor
0,046  0,043  Beta 2 adrenoreceptor antagonist
0,020  0,017  Neuraminidase (Influenza B) inhibitor
0,091  0,088  Antihelmintic (Fasciola)
0,024  0,022  Sodium/glucose cotransporter inhibitor
0,011  0,009  Immunosuppressant Cyclosporine-like
0,066  0,064  NAT1 substrate
0,011  0,009  Calcineurin inhibitor
0,049  0,047  Heparanase inhibitor
0,036  0,034  Vanilloid 3 antagonist
0,073  0,071  Carcinogenic, group 2A
0,026  0,024  Hedgehog signaling activator
0,049  0,048  Beta 1 adrenoreceptor antagonist
0,063  0,062  MDM2 inhibitor
0,024  0,023  Nicotinic acid receptor 2 antagonist
0,052  0,052  Sphingosine 1-phosphate receptor 3 antagonist

